Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 nCoV-19 COVID-19 vaccine trial in South African adults with and without HIV infection
PACTR202006922165132Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Jun 2020
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by University of Oxford. Started Jun 2020; status: completed.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202006922165132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006922165132.